<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01608113</url>
  </required_header>
  <id_info>
    <org_study_id>EK 802/2011</org_study_id>
    <nct_id>NCT01608113</nct_id>
  </id_info>
  <brief_title>Long-term Follow-up of Subfoveal Neovascular AMD</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      Treatment naive patients with subfoveal nAMD initially treated monthly with intravitreal
      anti-VEGF and subsequently PRN, will be included in this study. Patients will be investigated
      for the first 2 years monthly and subsequently according to disease activity but at least
      every two months. Patients will be examined with 4m BCVA ETDRS distance visual acuity,
      reading acuity measured by Radner-Reading-Charts, contrast sensitivity by Pelli-Robson score,
      microperimetry and HD-OCT.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term visual function performance</measure>
    <time_frame>four years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of morphological alterations assessed by SD-OCT</measure>
    <time_frame>four years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Exudative Age-related Macular Degeneration</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering on treatment naive subfoveal neovascular age-related macular
        degeneration
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  treatment naive subfoveal AMD, written informed consent, able to read

        Exclusion Criteria:

          -  choroidal neovascularisation due to other ocular diseases, mature cataract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher G Kiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1190</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmin Mitterm√ºller</last_name>
      <phone>00431404004847</phone>
    </contact>
    <contact_backup>
      <last_name>Germana Armberger</last_name>
      <phone>00431404004847</phone>
    </contact_backup>
    <investigator>
      <last_name>Florian Sulzbacher, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion Munk, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philipp Roberts, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katharina Eibenberger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2012</study_first_submitted>
  <study_first_submitted_qc>May 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>May 25, 2012</last_update_submitted>
  <last_update_submitted_qc>May 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Christopher Kiss</investigator_full_name>
    <investigator_title>Head of Vienna Study Center</investigator_title>
  </responsible_party>
  <keyword>neovascular AMD</keyword>
  <keyword>Optical coherence tomography</keyword>
  <keyword>reading acuity</keyword>
  <keyword>contrast sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Wet Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

